| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.0006 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.25 | 0.009 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |